ZA200007681B - Method of detecting an antibody in a liquid sample. - Google Patents

Method of detecting an antibody in a liquid sample. Download PDF

Info

Publication number: ZA200007681B
Authority: ZA; South Africa
Prior art keywords: antibody; complex; solid phase; component; sample
Prior art date: 1998-06-24

Application number

ZA200007681A

Other languages

English (en)

Inventor

Niels Johansen

Rikke Morkeberg

Soren Bogestrand

Beck Tine Charlotte

Hans Henrik Ipsen

Original Assignee

Alk Abello As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-24

Filing date

2000-12-20

Publication date

2001-06-06

2000-12-20 Application filed by Alk Abello As filed Critical Alk Abello As

2001-06-06 Publication of ZA200007681B publication Critical patent/ZA200007681B/en

Links

238000000034 method Methods 0.000 title claims description 155
239000007788 liquid Substances 0.000 title claims description 22
239000007790 solid phase Substances 0.000 claims description 110
239000002245 particle Substances 0.000 claims description 62
150000001875 compounds Chemical class 0.000 claims description 56
230000000694 effects Effects 0.000 claims description 56
238000005259 measurement Methods 0.000 claims description 49
239000003446 ligand Substances 0.000 claims description 43
208000026935 allergic disease Diseases 0.000 claims description 40
238000003556 assay Methods 0.000 claims description 40
206010020751 Hypersensitivity Diseases 0.000 claims description 38
230000007815 allergy Effects 0.000 claims description 38
239000007791 liquid phase Substances 0.000 claims description 36
239000000376 reactant Substances 0.000 claims description 35
230000005298 paramagnetic effect Effects 0.000 claims description 34
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 33
238000005406 washing Methods 0.000 claims description 33
239000000203 mixture Substances 0.000 claims description 29
238000002255 vaccination Methods 0.000 claims description 29
239000000427 antigen Substances 0.000 claims description 26
102000036639 antigens Human genes 0.000 claims description 26
108091007433 antigens Proteins 0.000 claims description 26
238000006243 chemical reaction Methods 0.000 claims description 25
239000007787 solid Substances 0.000 claims description 24
108010090804 Streptavidin Proteins 0.000 claims description 17
229960002685 biotin Drugs 0.000 claims description 16
235000020958 biotin Nutrition 0.000 claims description 16
239000011616 biotin Substances 0.000 claims description 16
238000011534 incubation Methods 0.000 claims description 16
238000002156 mixing Methods 0.000 claims description 12
238000001514 detection method Methods 0.000 claims description 11
230000001900 immune effect Effects 0.000 claims description 11
230000000977 initiatory effect Effects 0.000 claims description 11
108090001008 Avidin Proteins 0.000 claims description 10
-1 acridinium compound Chemical class 0.000 claims description 10
238000003018 immunoassay Methods 0.000 claims description 10
239000000470 constituent Substances 0.000 claims description 6
239000012071 phase Substances 0.000 claims description 6
238000000926 separation method Methods 0.000 claims description 5
230000002123 temporal effect Effects 0.000 claims description 5
108090000790 Enzymes Proteins 0.000 claims description 3
102000004190 Enzymes Human genes 0.000 claims description 3
238000002835 absorbance Methods 0.000 claims description 3
230000008859 change Effects 0.000 claims description 3
238000004587 chromatography analysis Methods 0.000 claims description 3
238000007885 magnetic separation Methods 0.000 claims description 3
230000002285 radioactive effect Effects 0.000 claims description 3
238000005119 centrifugation Methods 0.000 claims description 2
238000001914 filtration Methods 0.000 claims description 2
238000004062 sedimentation Methods 0.000 claims description 2
239000007850 fluorescent dye Substances 0.000 claims 2
FMXSYRBHGUMFBA-UHFFFAOYSA-N 6-amino-3-azaniumylidene-9-[2-carboxy-4-[6-[4-[4-[4-[4-[3-carboxy-6-[4-(trifluoromethyl)phenyl]naphthalen-1-yl]phenyl]piperidin-1-yl]butyl]triazol-1-yl]hexylcarbamoyl]phenyl]-5-sulfoxanthene-4-sulfonate Chemical compound Nc1ccc2c(-c3ccc(cc3C(O)=O)C(=O)NCCCCCCn3cc(CCCCN4CCC(CC4)c4ccc(cc4)-c4cc(cc5cc(ccc45)-c4ccc(cc4)C(F)(F)F)C(O)=O)nn3)c3ccc(=[NH2+])c(c3oc2c1S(O)(=O)=O)S([O-])(=O)=O FMXSYRBHGUMFBA-UHFFFAOYSA-N 0.000 claims 1
238000004440 column chromatography Methods 0.000 claims 1
238000011156 evaluation Methods 0.000 claims 1
239000000523 sample Substances 0.000 description 53
239000013566 allergen Substances 0.000 description 49
230000004044 response Effects 0.000 description 36
239000003153 chemical reaction reagent Substances 0.000 description 22
210000002966 serum Anatomy 0.000 description 22
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
235000009109 Betula pendula Nutrition 0.000 description 14
241000219430 Betula pendula Species 0.000 description 14
230000007012 clinical effect Effects 0.000 description 14
239000002953 phosphate buffered saline Substances 0.000 description 13
239000000243 solution Substances 0.000 description 13
241000238740 Dermatophagoides pteronyssinus Species 0.000 description 12
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
239000011534 wash buffer Substances 0.000 description 12
239000000126 substance Substances 0.000 description 11
238000012360 testing method Methods 0.000 description 11
230000002452 interceptive effect Effects 0.000 description 10
241000223602 Alternaria alternata Species 0.000 description 8
108010061629 Dermatophagoides pteronyssinus antigen p 1 Proteins 0.000 description 8
238000010790 dilution Methods 0.000 description 8
239000012895 dilution Substances 0.000 description 8
238000000338 in vitro Methods 0.000 description 8
108060003951 Immunoglobulin Proteins 0.000 description 7
102000018358 immunoglobulin Human genes 0.000 description 7
238000011084 recovery Methods 0.000 description 7
BAQMYDQNMFBZNA-UHFFFAOYSA-N N-biotinyl-L-lysine Natural products N1C(=O)NC2C(CCCCC(=O)NCCCCC(N)C(O)=O)SCC21 BAQMYDQNMFBZNA-UHFFFAOYSA-N 0.000 description 6
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 6
ATYCFNRXENKXSE-MHPIHPPYSA-N (2,5-dioxopyrrolidin-1-yl) 6-[6-[5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]hexanoylamino]hexanoate Chemical compound C([C@H]1[C@H]2NC(=O)N[C@H]2CS1)CCCC(=O)NCCCCCC(=O)NCCCCCC(=O)ON1C(=O)CCC1=O ATYCFNRXENKXSE-MHPIHPPYSA-N 0.000 description 5
230000005875 antibody response Effects 0.000 description 5
239000000428 dust Substances 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
239000000902 placebo Substances 0.000 description 5
229940068196 placebo Drugs 0.000 description 5
230000035945 sensitivity Effects 0.000 description 5
UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
230000014509 gene expression Effects 0.000 description 4
230000028993 immune response Effects 0.000 description 4
239000008363 phosphate buffer Substances 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
UVGHPGOONBRLCX-NJSLBKSFSA-N (2,5-dioxopyrrolidin-1-yl) 6-[5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]hexanoate Chemical compound C([C@H]1[C@H]2NC(=O)N[C@H]2CS1)CCCC(=O)NCCCCCC(=O)ON1C(=O)CCC1=O UVGHPGOONBRLCX-NJSLBKSFSA-N 0.000 description 3
235000018185 Betula X alpestris Nutrition 0.000 description 3
235000018212 Betula X uliginosa Nutrition 0.000 description 3
102000008100 Human Serum Albumin Human genes 0.000 description 3
108091006905 Human Serum Albumin Proteins 0.000 description 3
241000283973 Oryctolagus cuniculus Species 0.000 description 3
239000008351 acetate buffer Substances 0.000 description 3
230000000172 allergic effect Effects 0.000 description 3
208000010668 atopic eczema Diseases 0.000 description 3
230000006287 biotinylation Effects 0.000 description 3
238000007413 biotinylation Methods 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
238000011161 development Methods 0.000 description 3
231100000673 dose–response relationship Toxicity 0.000 description 3
230000009467 reduction Effects 0.000 description 3
230000002829 reductive effect Effects 0.000 description 3
239000013074 reference sample Substances 0.000 description 3
238000001542 size-exclusion chromatography Methods 0.000 description 3
AAYSIOJYGRABGS-UHFFFAOYSA-N 3-[9-[4-(2,5-dioxopyrrolidin-1-yl)oxycarbonyl-2,6-dimethylphenoxy]carbonylacridin-10-ium-10-yl]propane-1-sulfonate Chemical compound C=1C(C)=C(OC(=O)C=2C3=CC=CC=C3[N+](CCCS([O-])(=O)=O)=C3C=CC=CC3=2)C(C)=CC=1C(=O)ON1C(=O)CCC1=O AAYSIOJYGRABGS-UHFFFAOYSA-N 0.000 description 2
241001227713 Chiron Species 0.000 description 2
241000238631 Hexapoda Species 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
229920001213 Polysorbate 20 Polymers 0.000 description 2
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
230000008901 benefit Effects 0.000 description 2
BAQMYDQNMFBZNA-MNXVOIDGSA-N biocytin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCC[C@H](N)C(O)=O)SC[C@@H]21 BAQMYDQNMFBZNA-MNXVOIDGSA-N 0.000 description 2
239000013060 biological fluid Substances 0.000 description 2
239000008367 deionised water Substances 0.000 description 2
229910021641 deionized water Inorganic materials 0.000 description 2
239000003814 drug Substances 0.000 description 2
239000002532 enzyme inhibitor Substances 0.000 description 2
229940072221 immunoglobulins Drugs 0.000 description 2
239000000463 material Substances 0.000 description 2
238000012544 monitoring process Methods 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
210000002381 plasma Anatomy 0.000 description 2
239000002861 polymer material Substances 0.000 description 2
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
238000010181 skin prick test Methods 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
239000013026 undiluted sample Substances 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
RNIPJYFZGXJSDD-UHFFFAOYSA-N 2,4,5-triphenyl-1h-imidazole Chemical compound C1=CC=CC=C1C1=NC(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)N1 RNIPJYFZGXJSDD-UHFFFAOYSA-N 0.000 description 1
LRQKBLKVPFOOQJ-UHFFFAOYSA-N 2-aminohexanoic acid Chemical compound CCCCC(N)C(O)=O LRQKBLKVPFOOQJ-UHFFFAOYSA-N 0.000 description 1
241000238876 Acari Species 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
108050001427 Avidin/streptavidin Proteins 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
244000025254 Cannabis sativa Species 0.000 description 1
241000238713 Dermatophagoides farinae Species 0.000 description 1
108010061608 Dermatophagoides pteronyssinus antigen p 2 Proteins 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
241000283073 Equus caballus Species 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
238000000585 Mann–Whitney U test Methods 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
208000002193 Pain Diseases 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
241000009328 Perro Species 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
101710120037 Toxin CcdB Proteins 0.000 description 1
241001661641 Verrucosa Species 0.000 description 1
230000009471 action Effects 0.000 description 1
239000013543 active substance Substances 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
150000001413 amino acids Chemical group 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
210000003651 basophil Anatomy 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
239000000872 buffer Substances 0.000 description 1
125000000837 carbohydrate group Chemical group 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
239000012530 fluid Substances 0.000 description 1
239000013568 food allergen Substances 0.000 description 1
239000012634 fragment Substances 0.000 description 1
239000011521 glass Substances 0.000 description 1
125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
231100001039 immunological change Toxicity 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
238000002372 labelling Methods 0.000 description 1
KNJDBYZZKAZQNG-UHFFFAOYSA-N lucigenin Chemical compound [O-][N+]([O-])=O.[O-][N+]([O-])=O.C12=CC=CC=C2[N+](C)=C(C=CC=C2)C2=C1C1=C(C=CC=C2)C2=[N+](C)C2=CC=CC=C12 KNJDBYZZKAZQNG-UHFFFAOYSA-N 0.000 description 1
HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
230000005291 magnetic effect Effects 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
239000013618 particulate matter Substances 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
102000013415 peroxidase activity proteins Human genes 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
RXNXLAHQOVLMIE-UHFFFAOYSA-N phenyl 10-methylacridin-10-ium-9-carboxylate Chemical compound C12=CC=CC=C2[N+](C)=C2C=CC=CC2=C1C(=O)OC1=CC=CC=C1 RXNXLAHQOVLMIE-UHFFFAOYSA-N 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
239000001103 potassium chloride Substances 0.000 description 1
235000011164 potassium chloride Nutrition 0.000 description 1
239000008057 potassium phosphate buffer Substances 0.000 description 1
239000002243 precursor Substances 0.000 description 1
230000008569 process Effects 0.000 description 1
235000018102 proteins Nutrition 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
239000012064 sodium phosphate buffer Substances 0.000 description 1
229940043517 specific immunoglobulins Drugs 0.000 description 1
238000007619 statistical method Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Food Science & Technology (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Peptides Or Proteins (AREA)
Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Investigating Or Analysing Materials By Optical Means (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

ZA200007681A 1998-06-24 2000-12-20 Method of detecting an antibody in a liquid sample. ZA200007681B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DKPA199800821		1998-06-24

Publications (1)

Publication Number	Publication Date
ZA200007681B true ZA200007681B (en)	2001-06-06

Family

ID=8097940

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200007681A ZA200007681B (en)	1998-06-24	2000-12-20	Method of detecting an antibody in a liquid sample.

Country Status (15)

Country	Link
EP (1)	EP1090297B1 (de)
JP (1)	JP4523156B2 (de)
KR (1)	KR20010053162A (de)
CN (1)	CN1189749C (de)
AT (1)	ATE403866T1 (de)
AU (1)	AU752093B2 (de)
CA (1)	CA2335615C (de)
CZ (1)	CZ300237B6 (de)
DE (1)	DE69939260D1 (de)
DK (1)	DK1090297T3 (de)
ES (1)	ES2310939T3 (de)
HU (1)	HU228049B1 (de)
PL (1)	PL198236B1 (de)
WO (1)	WO1999067642A2 (de)
ZA (1)	ZA200007681B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8234099B2 (en)	1999-10-15	2012-07-31	Hemopet	Computer program for determining a nutritional diet product for a canine or feline animal
US7548839B2 (en)	1999-10-15	2009-06-16	Hemopet	System for animal health diagnosis
US6730023B1 (en)	1999-10-15	2004-05-04	Hemopet	Animal genetic and health profile database management
US6887472B2 (en)	2000-08-30	2005-05-03	Pfizer Inc.	Anti-IgE vaccines
US20050069962A1 (en)	2001-10-12	2005-03-31	Archer Robert M	Antibody complexes and methods for immunolabeling
AU2005217696B2 (en) *	2004-02-26	2008-02-14	Alk-Abello A/S	Method of evaluating the therapeutic potential of a vaccine for mucosal administration
US7873482B2 (en)	2008-12-16	2011-01-18	Bruno Stefanon	Diagnostic system for selecting nutrition and pharmacological products for animals
US7867720B2 (en)	2009-01-26	2011-01-11	Dodds W Jean	Food sensitivity testing in animals
US7892763B2 (en)	2009-01-26	2011-02-22	Dodds W Jean	Multi-stage nutrigenomic diagnostic food sensitivity testing in animals
US8450074B2 (en)	2009-01-26	2013-05-28	W. Jean Dodds	Multi-stage nutrigenomic diagnostic food sensitivity testing in animals
CN105277689A (zh) *	2015-11-17	2016-01-27	苏州浩欧博生物医药有限公司	纳米磁微粒化学发光法检测血清总IgE的试剂盒及方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4444879A (en) *	1981-01-29	1984-04-24	Science Research Center, Inc.	Immunoassay with article having support film and immunological counterpart of analyte
CA1240937A (en) *	1982-07-26	1988-08-23	Gordon R. Dreesman	Monoclonal igm antibodies and method of preparation
US4539292A (en) *	1982-12-29	1985-09-03	Reid Michael J	Immunoassay technique for specific immunoglobulin E
EP0119613B1 (de) *	1983-03-17	1992-07-29	BioWhittaker, Inc.	Fluorometrische Prüfung des gesamten IgE Niveaus und Reagens dafür
US5028524A (en) *	1987-04-24	1991-07-02	Takeda Chemical Industries, Ltd.	Assay for anti-pre-S antibody
DE3717401A1 (de) *	1987-05-23	1988-12-08	Behringwerke Ag	Einschritt-immuntest zur bestimmung von antigen-spezifischen antikoerpern aus einer der immunglobulin-klassen a, m, d oder e und dazu geeignetes mittel
WO1989012231A1 (en) *	1988-06-08	1989-12-14	Cambridge Bioscience Corporation	Anti-fc assay for detection of antibodies
JPH04503109A (ja) *	1989-01-30	1992-06-04	エピトープ，インコーポレイティド	アビジン―ビオチン助力のイムノアッセイ
US5965702A (en) *	1991-10-21	1999-10-12	Abbott Laboratories	Borrelia burgdorferi antigens and uses thereof
DK137992D0 (da) *	1992-11-13	1992-11-13	Alk Lab As	Fremgangsmaade til paavisning af et immunologisk aktivt stof i en proeve under anvendelse af et maerkningsstof
EP0705426A4 (de) *	1993-06-09	1998-07-08	Quidel Corp	Antigenspezifisches einstufiges verfahren
US5556759A (en) *	1993-08-02	1996-09-17	Beach; Peter G.	Assay and method for determining newborn risk for sudden infant death syndrome
WO1997001758A1 (en) *	1995-06-29	1997-01-16	Dako A/S	Method for the simultaneous detection of different antibodies and/or antigens
AU4821497A (en) *	1996-10-15	1998-05-11	Enteron, L.P.	Organism-specific and allergen-specific antibody capture assay and compositions for detection of disease-causing organisms and allergens

1999
- 1999-06-24 ES ES99929109T patent/ES2310939T3/es not_active Expired - Lifetime
- 1999-06-24 KR KR1020007014736A patent/KR20010053162A/ko not_active Ceased
- 1999-06-24 EP EP99929109A patent/EP1090297B1/de not_active Expired - Lifetime
- 1999-06-24 PL PL345727A patent/PL198236B1/pl not_active IP Right Cessation
- 1999-06-24 JP JP2000556248A patent/JP4523156B2/ja not_active Expired - Fee Related
- 1999-06-24 WO PCT/DK1999/000362 patent/WO1999067642A2/en not_active Ceased
- 1999-06-24 AT AT99929109T patent/ATE403866T1/de active
- 1999-06-24 CA CA2335615A patent/CA2335615C/en not_active Expired - Fee Related
- 1999-06-24 DE DE69939260T patent/DE69939260D1/de not_active Expired - Lifetime
- 1999-06-24 DK DK99929109T patent/DK1090297T3/da active
- 1999-06-24 CZ CZ20004867A patent/CZ300237B6/cs not_active IP Right Cessation
- 1999-06-24 AU AU46033/99A patent/AU752093B2/en not_active Ceased
- 1999-06-24 CN CNB998088463A patent/CN1189749C/zh not_active Expired - Fee Related
- 1999-06-24 HU HU0103177A patent/HU228049B1/hu not_active IP Right Cessation
2000
- 2000-12-20 ZA ZA200007681A patent/ZA200007681B/en unknown

Also Published As

Publication number	Publication date
CZ300237B6 (cs)	2009-03-25
HUP0103177A3 (en)	2005-11-28
ATE403866T1 (de)	2008-08-15
PL345727A1 (en)	2002-01-02
EP1090297B1 (de)	2008-08-06
WO1999067642A3 (en)	2000-06-02
CA2335615C (en)	2010-08-10
AU4603399A (en)	2000-01-10
CN1189749C (zh)	2005-02-16
HU228049B1 (en)	2012-09-28
AU752093B2 (en)	2002-09-05
CZ20004867A3 (cs)	2001-08-15
CA2335615A1 (en)	1999-12-29
EP1090297A2 (de)	2001-04-11
JP4523156B2 (ja)	2010-08-11
ES2310939T3 (es)	2009-01-16
HUP0103177A2 (hu)	2001-12-28
PL198236B1 (pl)	2008-06-30
KR20010053162A (ko)	2001-06-25
HK1035227A1 (en)	2001-11-16
CN1310799A (zh)	2001-08-29
JP2002519638A (ja)	2002-07-02
DE69939260D1 (de)	2008-09-18
DK1090297T3 (da)	2009-01-19
WO1999067642A2 (en)	1999-12-29

Publication	Publication Date	Title
ES2340667T3 (es)	2010-06-08	Inmunodeficiencia homogeneos para multiples alergenos.
JP5744385B2 (ja)	2015-07-08	Ｃｖｄ分析
KR920000056B1 (ko)	1992-01-06	특이적으로 결합가능한 물질의 측정방법
CN108291912A (zh)	2018-07-17	减少免疫测定法中的干扰的方法
CA2335615C (en)	2010-08-10	Method of detecting an antibody in a liquid sample
CN110488025A (zh)	2019-11-22	一种化学发光定量检测粪便钙卫蛋白及其检测方法和其在肠道健康检测的用途
CA3181751A1 (en)	2021-12-16	Detection of antibodies to sars-cov-2
HU216876B (hu)	1999-09-28	Eljárás ellenanyag kimutatására kemilumineszcens jelőlőanyaghoz és biotinhoz kötött ligandum alkalmazásával
US20070224654A1 (en)	2007-09-27	Method of detecting an antibody in a liquid sample
US7759133B2 (en)	2010-07-20	Method of detecting and/or quantifying a specific IgE antibody in a liquid sample
JP2021529948A (ja)	2021-11-04	自己抗体の直接イムノアッセイ測定法
Merrett et al.	1978	Methods of quantifying circulating IgE
CA2090392C (en)	2000-01-11	Coupling of antigens and antibodies to non-fixed erythrocytes
HK1035227B (en)	2009-01-30	Method of detecting an antibody in a liquid sample
JP4636225B2 (ja)	2011-02-23	検査試薬キット
JP2005308701A (ja)	2005-11-04	抗腎タイプｉｖモノクロ−ナル抗体
JPH03197866A (ja)	1991-08-29	多項目同時判定能を有する免疫測定用試薬及び多項目同時判定免疫測定方法